MS Disease – Multiple Sclerosis Explained Simply

What is MS Disease?

MS disease, commonly known as Multiple Sclerosis (MS) or by its medical name Encephalomyelitis disseminata, is a chronic inflammatory disease of the central nervous system (CNS) affecting the brain and spinal cord. In MS, the body's own immune system mistakenly attacks the myelin sheath – the protective coating around nerve fibers that enables fast and efficient transmission of nerve signals. This damage creates areas of scarring called lesions (from the Latin word sclerosis), which disrupt normal nerve communication.

Multiple Sclerosis is one of the most common neurological disorders among young adults. An estimated 2.8 million people worldwide are affected, with approximately 1 million in the United States alone. Women are diagnosed about twice as often as men, and the condition most commonly develops between the ages of 20 and 40.

Causes and Risk Factors

The exact cause of MS disease remains unclear. Current research suggests a combination of several contributing factors:

• Genetic predisposition: Certain gene variants increase susceptibility to MS, although genetics alone do not determine whether the disease develops.
• Immune system dysfunction: The immune system incorrectly identifies the body's own myelin as a foreign threat and attacks it (autoimmune reaction).
• Environmental triggers: Low vitamin D levels, limited sun exposure, and infections – particularly with the Epstein-Barr virus – have been associated with increased MS risk.
• Smoking: Increases the risk of developing MS and is linked to faster disease progression.
• Geographic factors: MS is more prevalent in regions further from the equator with less sunlight exposure.

Symptoms

The symptoms of MS disease vary widely depending on which parts of the CNS are affected. Common symptoms include:

• Vision problems (e.g., optic neuritis – inflammation of the optic nerve causing blurred vision or temporary vision loss)
• Numbness and tingling in the arms, legs, or face
• Muscle weakness and partial paralysis
• Problems with coordination and balance
• Fatigue – an extreme and debilitating exhaustion, often described as the most disabling symptom
• Bladder and bowel dysfunction
• Cognitive difficulties (problems with memory and concentration)
• Depression and mood changes
• Spasticity – involuntary muscle stiffness and spasms

Types of MS

MS disease does not follow the same course in every person. The main types are:

• Relapsing-remitting MS (RRMS): The most common form (approximately 85% of initial diagnoses). Periods of acute relapses alternate with periods of partial or full recovery.
• Secondary progressive MS (SPMS): Often develops from RRMS. Neurological function worsens progressively, with or without distinct relapses.
• Primary progressive MS (PPMS): Characterized by steady worsening of neurological function from the onset, without early relapses. Affects approximately 10–15% of people with MS.
• Clinically isolated syndrome (CIS): A first episode of neurological symptoms suggesting MS, but not yet meeting the full diagnostic criteria.

Diagnosis

Diagnosing MS disease is a complex process that requires ruling out other conditions. Key diagnostic tools include:

• MRI (Magnetic Resonance Imaging): The gold standard for detecting lesions in the brain and spinal cord.
• Lumbar puncture (spinal tap): Analysis of cerebrospinal fluid for inflammatory markers, such as oligoclonal bands.
• Evoked potentials: Tests measuring nerve conduction speed to detect subclinical damage.
• Neurological examination: Assessment of reflexes, coordination, sensation, and cognitive function.
• McDonald criteria: Internationally recognized diagnostic criteria that evaluate the dissemination of lesions in time and location.

Treatment

There is currently no cure for MS disease. Treatment focuses on reducing relapses, slowing disease progression, and improving quality of life.

Relapse Treatment

Acute relapses are typically treated with high-dose corticosteroids (methylprednisolone), which reduce inflammation and shorten recovery time.

Disease-Modifying Therapies (DMTs)

Long-term therapies aim to reduce the frequency and severity of relapses. Options include:

• Interferon beta preparations and glatiramer acetate (moderate efficacy)
• Dimethyl fumarate, teriflunomide, fingolimod (moderate to high efficacy)
• Natalizumab, ocrelizumab, alemtuzumab (high-efficacy therapies for active or aggressive MS)

Symptomatic Treatment

Additional therapies address individual symptoms such as spasticity, fatigue, pain, and bladder dysfunction, using both medications and non-pharmacological approaches.

Rehabilitation and Physiotherapy

Physical therapy, occupational therapy, speech therapy, and neuropsychological support are vital components of comprehensive MS care, helping patients maintain daily functioning and independence.

Living with MS

Many people with MS disease lead fulfilling and largely normal lives. Regular physical activity, a balanced diet, stress management, and close collaboration with a specialized neurology team play a key role in disease management. Support groups and psychological counseling can also provide valuable assistance.

References

1. Thompson AJ et al. – Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 2018; 17(2): 162–173.
2. World Health Organization (WHO) – Atlas of MS, 3rd edition. Geneva: WHO Press, 2020.
3. National Multiple Sclerosis Society (NMSS) – What is MS? www.nationalmssociety.org (2024)